Skip to main content

Table 2 The clinical characteristics of patients infected with COVID-19

From: Relationship between glucocorticoids and viral load during the Omicron wave in mainland China

Variables

Covid-19 infected

(n = 78)

Glucocorticoid used

(n = 50)

Non-Glucocorticoid used (n = 28)

P value

Life-sustaining treatments (n (%))

 Mechanical ventilation

7(9)

4 (8)

3 (10.7)

0.687

 NIPPV

3(3.8)

2(4)

1 (3.6)

0.925

 HFNC

28(35.9)

20(40)

8(28.6)

0.313

 Venturi Mask

46(59)

32(64)

14(50)

0.228

 ECMO

1(1.3)

1(2)

0

0.451

 Need for vasopressor

7 (9)

3 (6)

4 (14.3)

0.219

 Need for RRT

1 (1.3)

1(2)

0

0.451

Other Pathogens (n (%))

 Bacteria

16 (20.5)

12 (24)

4 (14.3)

0.308

 Fungal

12 (15.4)

8 (16)

4 (14.3)

0.84

Biochemical parameters at Emergency admission (median (IQR))

 Albumin (g/L)

33.5 (7)

34.5(6)

33(7)

0.607

 Serum Creatinine (μmol/L)

86 (41)

89(60)

80.5(42)

0.185

 Total Bilirubin (μmol/L)

19.9 (31.2)

19.6(37)

20.9(25.1)

0.149

 D-dimer (mg/L)

1.88 (8.68)

1.88(10.47)

1.91(8.02)

0.447

Infection marker at Emergency admission (median (IQR))

 Procalcitonin (ng/mL)

0.15 (0.58)

0.16 (0.5)

0.11(0.68)

0.757

 CPIS

6 (2)

6 (2)

6 (2)

0.34

 Murray Score

2(2.67)

2(1.17)

1.75(2.17)

0.319

Outcome

    

 Hospital stay

 (days) (median(IQR))

13.5(10)

13.5(10)

12.5 (10)

0.562

 in-Hospital mortality (n(%))

14 (17.9)

10 (20)

3 (10.7)

0.291

 28 days mortality (n(%))

12 (15.4)

9 (18)

3 (10.7)

0.392

  1. Data are number of patients (%) or median and interquartile range (median [IQR]); NIPPV: nasal intermittent positive pressure ventilation; HFNC: high flow nasal cannula; ECMO: extracorporeal membrane oxygenation; RRT: renal replace treatment; CPIS: Clinical pulmonary infection scores